October 4, 2005
Case Western Reserve University
As one of the services for patients with Alzheimer's disease, the Department of Psychiatry at the Saarland University Medical Center offers participation in a clinical phase II trial. This clinical trial aims to elucidate a potential beneficial effect of copper orotate (an organic copper salt), which is given together with a standard cholinesterase inhibitor. A diagnosis of mild to moderate dementia of the Alzheimer type is a prerequisite.
The above story is based on materials provided by Case Western Reserve University. Note: Materials may be edited for content and length.
Cite This Page:
Case Western Reserve University. "Intake Of Dietary Copper Helps Alzheimer's Patients." ScienceDaily. ScienceDaily, 4 October 2005. <www.sciencedaily.com/releases/2005/10/051004084327.htm>.
Case Western Reserve University. (2005, October 4). Intake Of Dietary Copper Helps Alzheimer's Patients. ScienceDaily. Retrieved March 11, 2014 from www.sciencedaily.com/releases/2005/10/051004084327.htm
Case Western Reserve University. "Intake Of Dietary Copper Helps Alzheimer's Patients." ScienceDaily. www.sciencedaily.com/releases/2005/10/051004084327.htm (accessed March 11, 2014).